Moderna braces for earnings and FDA catalyst
Moderna is approaching two major events – the company's quarterly earnings report and the FDA's decision on its seasonal influenza vaccine. Against this backdrop, investors are taking profits, while the stock's volatility is gradually increasing.
Investor attention remains focused on the FDA's decision regarding Moderna's mRNA-1010 seasonal influenza vaccine, which is expected on August 5. Approval would make Moderna the first company to bring an mRNA-based seasonal flu vaccine to market. According to the company, the technology allows for more precise matching to circulating virus strains while enabling faster manufacturing updates for new seasonal variants.
Until the FDA announces its decision, investors are likely to remain cautious. Following the stock's strong rally in recent months, Moderna has entered a phase of profit-taking, while market attention shifts toward the U.S. earnings season, which typically brings higher volatility.
Moderna must reclaim $68 to restore bullish momentum
The previously expected bullish scenario did not materialize. Instead, Moderna shares experienced a classic sell-the-news reaction and fell below the key $68 support level. After several months of strong gains, both short- and medium-term investors began locking in profits, adding pressure to the stock.
To restore bullish momentum, Moderna must reclaim the $68 level. If buyers succeed, the next upside target will be the resistance zone near $73.30.
If sellers remain in control, a deeper pullback toward the next major support area around $60 cannot be ruled out.
Earnings season could spark bigger moves in Moderna
Ahead of Moderna's July 31 earnings report, the stock is likely to remain driven by overall market sentiment. The start of the earnings season has already shown that investors are highly sensitive to even minor deviations from expectations.
As a result, MRNA shares could experience significantly higher volatility over the coming weeks.
Latest Moderna News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
